BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 33544565)

  • 1. Immunophenotypic Spectrum and Genomic Landscape of Refractory Celiac Disease Type II.
    Soderquist CR; Lewis SK; Gru AA; Vlad G; Williams ES; Hsiao S; Mansukhani MM; Park DC; Bacchi CE; Alobeid B; Green PH; Bhagat G
    Am J Surg Pathol; 2021 Jul; 45(7):905-916. PubMed ID: 33544565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis of Enteropathy-Associated T Cell Lymphoma.
    Chander U; Leeman-Neill RJ; Bhagat G
    Curr Hematol Malig Rep; 2018 Aug; 13(4):308-317. PubMed ID: 29943210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenetic landscape of lymphomagenesis in coeliac disease.
    Cording S; Lhermitte L; Malamut G; Berrabah S; Trinquand A; Guegan N; Villarese P; Kaltenbach S; Meresse B; Khater S; Dussiot M; Bras M; Cheminant M; Tesson B; Bole-Feysot C; Bruneau J; Molina TJ; Sibon D; Macintyre E; Hermine O; Cellier C; Asnafi V; Cerf-Bensussan N;
    Gut; 2022 Mar; 71(3):497-508. PubMed ID: 33579790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Refractory celiac disease type II: An atypical case highlighting limitations of the current classification system.
    Soderquist CR; Hsiao S; Mansukhani MM; Alobeid B; Green PH; Bhagat G
    Hematol Oncol; 2020 Aug; 38(3):399-405. PubMed ID: 32010998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometric determination of aberrant intra-epithelial lymphocytes predicts T-cell lymphoma development more accurately than T-cell clonality analysis in Refractory Celiac Disease.
    Verbeek WH; Goerres MS; von Blomberg BM; Oudejans JJ; Scholten PE; Hadithi M; Al-Toma A; Schreurs MW; Mulder CJ
    Clin Immunol; 2008 Jan; 126(1):48-56. PubMed ID: 18024205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enteropathy-associated T-cell lymphoma complicating an autoimmune enteropathy.
    Malamut G; Verkarre V; Callens C; Colussi O; Rahmi G; MacIntyre E; Haïoun C; Meresse B; Brousse N; Romana S; Hermine O; Cerf-Bensussan N; Cellier C
    Gastroenterology; 2012 Apr; 142(4):726-729.e3; quiz e13-4. PubMed ID: 22226659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Intracellular Intensity of CD3 on Aberrant Intraepithelial Lymphocytes Is a Prognostic Factor of the Progression to Overt Lymphoma in Refractory Celiac Disease Type II (Pre-Enteropathy-Associated T Cell Lymphoma).
    García-Hoz C; Crespo L; Lopez N; De Andrés A; Ríos León R; Santón A; Garriga M; Butz E; León F; Roy Ariño G
    Dig Dis; 2020; 38(6):490-499. PubMed ID: 32015237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular and molecular bases of refractory celiac disease.
    Soderquist CR; Bhagat G
    Int Rev Cell Mol Biol; 2021; 358():207-240. PubMed ID: 33707055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 18F-FDG PET versus CT for the detection of enteropathy-associated T-cell lymphoma in refractory celiac disease.
    Hadithi M; Mallant M; Oudejans J; van Waesberghe JH; Mulder CJ; Comans EF
    J Nucl Med; 2006 Oct; 47(10):1622-7. PubMed ID: 17015897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type II enteropathy-associated T-cell lymphoma features a unique genomic profile with highly recurrent SETD2 alterations.
    Roberti A; Dobay MP; Bisig B; Vallois D; Boéchat C; Lanitis E; Bouchindhomme B; Parrens MC; Bossard C; Quintanilla-Martinez L; Missiaglia E; Gaulard P; de Leval L
    Nat Commun; 2016 Sep; 7():12602. PubMed ID: 27600764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic and phenotypic characterization of indolent T-cell lymphoproliferative disorders of the gastrointestinal tract.
    Soderquist CR; Patel N; Murty VV; Betman S; Aggarwal N; Young KH; Xerri L; Leeman-Neill R; Lewis SK; Green PH; Hsiao S; Mansukhani MM; Hsi ED; de Leval L; Alobeid B; Bhagat G
    Haematologica; 2020 Jul; 105(7):1895-1906. PubMed ID: 31558678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucosal intraepithelial T-lymphocytes in refractory celiac disease: a neoplastic population with a variable CD8 phenotype.
    de Mascarel A; Belleannée G; Stanislas S; Merlio C; Parrens M; Laharie D; Dubus P; Merlio JP
    Am J Surg Pathol; 2008 May; 32(5):744-51. PubMed ID: 18360280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic and immunohistochemical profiles of enteropathy-associated T-cell lymphoma in Japan.
    Tomita S; Kikuti YY; Carreras J; Kojima M; Ando K; Takasaki H; Sakai R; Takata K; Yoshino T; Bea S; Campo E; Nakamura N
    Mod Pathol; 2015 Oct; 28(10):1286-96. PubMed ID: 26226842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring nonresponsive patients who have celiac disease.
    Krauss N; Schuppan D
    Gastrointest Endosc Clin N Am; 2006 Apr; 16(2):317-27. PubMed ID: 16644460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Refractory coeliac disease: a window between coeliac disease and enteropathy associated T cell lymphoma.
    Mulder CJ; Wahab PJ; Moshaver B; Meijer JW
    Scand J Gastroenterol Suppl; 2000; (232):32-7. PubMed ID: 11232488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enteropathy-associated T cell lymphoma subtypes are characterized by loss of function of SETD2.
    Moffitt AB; Ondrejka SL; McKinney M; Rempel RE; Goodlad JR; Teh CH; Leppa S; Mannisto S; Kovanen PE; Tse E; Au-Yeung RKH; Kwong YL; Srivastava G; Iqbal J; Yu J; Naresh K; Villa D; Gascoyne RD; Said J; Czader MB; Chadburn A; Richards KL; Rajagopalan D; Davis NS; Smith EC; Palus BC; Tzeng TJ; Healy JA; Lugar PL; Datta J; Love C; Levy S; Dunson DB; Zhuang Y; Hsi ED; Dave SS
    J Exp Med; 2017 May; 214(5):1371-1386. PubMed ID: 28424246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant T-lymphocytes in refractory coeliac disease are not strictly confined to a small intestinal intraepithelial localization.
    Verbeek WH; von Blomberg BM; Coupe VM; Daum S; Mulder CJ; Schreurs MW
    Cytometry B Clin Cytom; 2009 Nov; 76(6):367-74. PubMed ID: 19444812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-cell repertoires in refractory coeliac disease.
    Ritter J; Zimmermann K; Jöhrens K; Mende S; Seegebarth A; Siegmund B; Hennig S; Todorova K; Rosenwald A; Daum S; Hummel M; Schumann M
    Gut; 2018 Apr; 67(4):644-653. PubMed ID: 28188172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The MYO9B gene is a strong risk factor for developing refractory celiac disease.
    Wolters VM; Verbeek WH; Zhernakova A; Onland-Moret C; Schreurs MW; Monsuur AJ; Verduijn W; Wijmenga C; Mulder CJ
    Clin Gastroenterol Hepatol; 2007 Dec; 5(12):1399-405, 1405.e1-2. PubMed ID: 17967566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience.
    Al-Toma A; Verbeek WH; Hadithi M; von Blomberg BM; Mulder CJ
    Gut; 2007 Oct; 56(10):1373-8. PubMed ID: 17470479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.